Axsome Therapeutics (NASDAQ:AXSM) Stock Price Expected to Rise, Robert W. Baird Analyst Says
Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) had its price objective hoisted by stock analysts at Robert W. Baird from $132.00 to $160.00 in a note issued to investors on Monday,Benzinga reports. The firm currently has an “outperform” rating on the stock. Robert W. Baird’s price objective would suggest a potential upside of 27.42% from […]
Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) had its price objective hoisted by stock analysts at Robert W. Baird from $132.00 to $160.00 in a note issued to investors on Monday,Benzinga reports. The firm currently has an “outperform” rating on the stock. Robert W. Baird’s price objective would suggest a potential upside of 27.42% from […]
